Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Researchers use suction method to deliver SARS-CoV-2 DNA vaccine in lab tests

Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.

6 Nov 2021

School-based screening can help tackle depression in youth

Students who participated in universal school-based depression screening were twice as likely to begin treatment compared to their peers who did not receive this screening, according to a new study by Penn State College of Medicine researchers.

6 Nov 2021

Study uncovers a process in cells that may limit infectivity of SARS-CoV-2

Scientists at the National Institutes of Health have found that a process in cells may limit infectivity of SARS-CoV-2, and that mutations in the alpha and delta variants overcome this effect, potentially boosting the virus's ability to spread.

6 Nov 2021

‘Covid hit us over the head with a two-by-four’: Addressing ageism with urgency

Earlier this year, the World Health Organization announced a global campaign to combat ageism — discrimination against older adults that is pervasive and harmful but often unrecognized.

5 Nov 2021

Return to school testing initiative addresses the needs of underserved communities

Safe, in-person school during the COVID-19 pandemic requires research that involves community engagement in underserved or vulnerable areas of the United States, writes Alison Cernich, Ph.D., deputy director of NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and colleagues.

5 Nov 2021

Study finds benefits of COVID vaccination in pregnancy outweighs risks

A new preprint explores the efficacy of vaccination against infection with SARS-CoV-2 in pregnancy.

4 Nov 2021

Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

A new preprint describes the protective efficacy of memory T-cells developed in response to the viral antigen, which could offer long-term immunity.

4 Nov 2021

“Catching SARS-CoV-2 in the act” – viral infection of nasal mucosa spares nerve cells

A new study discusses the entry of SARS-CoV-2 into the respiratory and olfactory mucosa of the nasal cavity.

4 Nov 2021

Study shows most young Australians are willing to be tested for COVID

A new study explores the success of testing efforts among children and adolescents in Australia.

4 Nov 2021

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

A new study describes the results of the safety and efficacy phase trials of a new COVID-19 vaccine from Cuba.

4 Nov 2021

Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

A new study explores the acceptability and usage of COVID-19 vaccines among the student community.

4 Nov 2021

Aptamer Group and DeepVerge expand partnership for Optimer-enabled wastewater monitoring

Aptamer Group Ltd., the developer of Optimer® binders to enable innovation in the life science industry, is pleased to announce the expansion of its existing partnership with DeepVerge PLC.

4 Nov 2021

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

A team of scientists has recently developed an allele-specific probe polymerase chain reaction method that can accurately detect different variants/lineages of SARS-CoV-2 in respiratory samples.

4 Nov 2021

SARS-CoV-2 detected in white-tailed deer with possible zooanthroponotic spillover events

The study aimed to test the hypothesis that the infection and transmission of SARS-CoV-2 of deer occurred in nature.

4 Nov 2021

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.

4 Nov 2021

Cas13 shines a light on SARS-CoV-2 variants

Now, a new study published on the medRxiv* preprint server describes and benchmarks SHINEv2, a Cas13-based nucleic acid diagnostic for SARS-CoV-2 detection. SHINEv2 combines temperature sample processing and lyophilized reagents to simplify the test procedure and assay distribution immensely.

4 Nov 2021